American multinational healthcare services company specializing in pharmaceutical distribution, medical products, and healthcare technology solutions.
Company Type
public
Founded
1971
Headquarters
Dublin, Ohio, USA
Stock
NYSE: CAH
Revenue
approximately $226.0 billion (FY2025)
Employees
Approximately 49,000
Primary Market
United States
Cardinal Health operates through several key business segments focused on healthcare distribution and services. The Pharmaceutical segment distributes brand-name and generic pharmaceuticals to pharmacies, hospitals, and healthcare providers across the United States and internationally.
The Medical segment manufactures and distributes medical and surgical products, including gloves, surgical gowns, and other medical supplies. The company also operates nuclear pharmacies that prepare and deliver radiopharmaceuticals for medical imaging and cancer treatment.
Cardinal Health provides various healthcare technology solutions, including pharmacy management systems, supply chain management tools, and data analytics platforms. The company has expanded into at-home healthcare services, delivering medical supplies and pharmaceuticals directly to patients' homes.
Cardinal Health employs approximately 47,000 people worldwide and generates annual revenues exceeding $180 billion. The company serves pharmacies, hospitals, healthcare systems, and manufacturers across the United States and select international markets.
Cardinal Health was founded in 1971 by Robert Walter as a small food distributor in Columbus, Ohio. The company entered the pharmaceutical distribution business in 1979, marking a strategic shift toward healthcare services. Throughout the 1980s, Cardinal Health expanded its pharmaceutical distribution operations and went public in 1983.
The company grew rapidly through acquisitions in the 1980s and 1990s, becoming one of the largest pharmaceutical distributors in the United States. In 1994, Cardinal Health acquired the medical and surgical products business of Baxter International, significantly expanding its medical products portfolio.
Throughout the 2000s and 2010s, Cardinal Health continued to expand through strategic acquisitions and organic growth. The company expanded internationally, particularly in Europe and Latin America. In 2009, Cardinal Health spun off its clinical and medical products businesses into CareFusion, which was later acquired by BD.
In recent years, Cardinal Health has focused on expanding its specialty pharmaceuticals business, healthcare technology solutions, and at-home healthcare services. The company has invested heavily in digital health platforms and data analytics to enhance its healthcare delivery capabilities.
Cardinal Health has established comprehensive sustainability and ethics initiatives focused on healthcare access, pharmaceutical distribution, medical supply chain, and responsible healthcare practices. The company's commitment to improving healthcare outcomes extends to its environmental and social responsibility programs.
Cardinal Health plays a crucial role in improving healthcare access through efficient pharmaceutical distribution and medical supply chain management. The company's distribution networks ensure that healthcare providers and patients have access to essential medications and medical supplies. Cardinal Health's healthcare access initiatives focus on reaching underserved communities, supporting rural healthcare providers, and ensuring medication availability during public health emergencies.
The company operates with strong sustainability practices in medical supply chain management, including efficient logistics, waste reduction, and environmentally responsible distribution practices. Cardinal Health has implemented programs to reduce packaging waste, optimize transportation routes, and promote sustainable medical product manufacturing. The company's supply chain initiatives focus on reducing environmental impact while maintaining healthcare quality and safety.
Cardinal Health maintains strong ethical standards in healthcare distribution, pharmaceutical pricing, and medical supply management. The company operates with comprehensive compliance programs for regulatory requirements, anti-corruption measures, and ethical business practices. Cardinal Health's ethical practices include transparent pricing, fair competition, and responsible pharmaceutical distribution practices.
The company invests in sustainable healthcare technology solutions that improve patient outcomes while reducing healthcare costs. Cardinal Health's digital health initiatives include pharmacy management systems, supply chain optimization tools, and data analytics platforms that enhance healthcare efficiency. The company's technology investments focus on creating sustainable healthcare delivery models that improve access and reduce waste.
Cardinal Health maintains strong community engagement programs focused on healthcare education, disease prevention, and community health improvement. The company supports local health initiatives, medical education programs, and community health clinics. Cardinal Health's community health initiatives include medication adherence programs, health education campaigns, and support for healthcare workforce development.
Cardinal Health has implemented environmental sustainability initiatives across its operations, including energy-efficient facilities, renewable energy use, and waste reduction programs. The company's environmental practices focus on reducing carbon footprint, promoting sustainable healthcare practices, and minimizing environmental impact of medical product distribution.
Cardinal Health has received extensive recognition for its contributions to healthcare distribution, supply chain excellence, and community health initiatives.
Cardinal Health has been acknowledged for its community health programs and social impact initiatives. The company's healthcare education programs, community health clinics, and medication adherence campaigns have received recognition from healthcare organizations and community groups.
Cardinal Health operates in the highly regulated healthcare industry and faces scrutiny related to drug pricing, distribution practices, and the complex challenges facing healthcare companies.
Cardinal Health has faced scrutiny regarding drug pricing practices and pharmaceutical distribution margins. The company's role in the pharmaceutical supply chain has drawn attention from regulators and policymakers concerned about drug costs and pricing transparency. Cardinal Health must balance business objectives with regulatory requirements and public expectations regarding affordable healthcare.
The company operates under extensive regulatory scrutiny from FDA, DEA, and other healthcare regulatory agencies. Cardinal Health faces ongoing examination regarding compliance with pharmaceutical distribution regulations, controlled substance handling, and healthcare quality standards. The company must maintain complex compliance programs across multiple regulatory jurisdictions.
Cardinal Health's role in pharmaceutical distribution has drawn scrutiny regarding drug shortages and supply chain disruptions. The company faces questions about its ability to maintain adequate medication supplies during public health emergencies and natural disasters. Regulators and healthcare providers examine Cardinal Health's supply chain resilience and emergency response capabilities.
As one of the largest pharmaceutical distributors, Cardinal Health faces scrutiny regarding market concentration and competitive practices. The company's market position has drawn attention from antitrust regulators and competitors concerned about market power and competitive fairness in healthcare distribution.
Cardinal Health's expansion into healthcare technology and data analytics has raised questions about data privacy and security. The company must navigate complex healthcare data regulations, including HIPAA compliance and patient privacy protection, while developing innovative technology solutions.
The company's medical product distribution and healthcare operations face scrutiny regarding environmental impact and medical waste management. Cardinal Health must address concerns about packaging waste, transportation emissions, and sustainable healthcare practices while maintaining product safety and quality.
Cardinal Health owns 3 brands in our database.

Owned by Cardinal Health
At-home healthcare solutions provider delivering medical supplies, equipment, and pharmacy services directly to patients' homes owned by Cardinal Health.

Owned by Cardinal Health
Radiopharmaceutical and nuclear medicine solutions provider offering PET and SPECT radiopharmaceuticals and nuclear pharmacy services owned by Cardinal Health.

Owned by Cardinal Health
Specialty pharmaceutical distribution and services provider serving specialty pharmacies, hospitals, and healthcare providers with complex medications owned by Cardinal Health.
Cardinal Health is an independent, publicly traded corporation with no parent company. The company operates independently with its own management structure and board of directors, though it has grown through numerous acquisitions throughout its history.
Yes, Cardinal Health is publicly traded on the New York Stock Exchange under the ticker symbol CAH. The company has been publicly traded since its IPO in 1983, allowing investors to purchase shares and own a portion of the company.
Cardinal Health was founded in 1971 by Robert Walter as a food distributor. The company entered the pharmaceutical distribution business in 1979, marking the beginning of its transformation into a healthcare services company.
Cardinal Health was founded by Robert Walter, who started the company as a small food distributor in Columbus, Ohio. Walter's vision and leadership guided the company's transformation into one of the largest healthcare distribution companies in the world.
Cardinal Health is one of the largest pharmaceutical distribution companies globally by revenue and a critical component of the healthcare supply chain. The company maintains strong positions in pharmaceutical distribution, medical products, and healthcare technology solutions, serving healthcare providers across the United States and internationally.
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.

American pharmaceutical distribution company specializing in drug distribution and healthcare solutions, formerly known as AmerisourceBergen.
8 brands in portfolio

American multinational healthcare company providing managed care services and health insurance solutions for government-sponsored healthcare programs.
4 brands in portfolio

American health benefits company providing medical, pharmacy, behavioral, and dental insurance products and services, formerly known as Anthem.
4 brands in portfolio

American healthcare company specializing in pharmaceutical distribution, medical supplies, and healthcare technology solutions.
4 brands in portfolio

American integrated healthcare company operating CVS Pharmacy, Aetna health insurance, CVS Caremark pharmacy benefits management, and MinuteClinic, publicly traded on the NYSE.
7 brands in portfolio

Leading American healthcare company providing health insurance, pharmacy benefits management, and healthcare technology services to millions of customers globally.
7 brands in portfolio